Table 1.
Clinical and demographic characteristics of COVID-19 patients in the MGH cohort.
| Critical (A1, A2) | Non-Critical (A3, A4, A5) | P-value | |
|---|---|---|---|
| (n=109) | (n=196) | ||
| Age group, n (%) | <0.01 | ||
| Under 65 years | 45 (41.3) | 141 (71.9) | |
| 65-79 years | 37 (33.9) | 28 (14.3) | |
| 80 years or over | 27 (24.8) | 27 (13.8) | |
| BMI group, n (%) | 0.19 | ||
| Under 25.0 | 19 (17.4) | 27 (13.8) | |
| 25.0-39.9 | 73 (67.0) | 131 (66.8) | |
| Over 40.0 | 13 (11.9) | 22 (11.2) | |
| Unknown | 4 (3.7) | 16 (8.2) | |
| Comorbidities, n (%) | |||
| Hypertension | 65 (59.6) | 81 (41.3) | <0.01 |
| Diabetes | 50 (45.9) | 60 (30.6) | <0.01 |
| 28-day death, n (%) | 42 (38.5) | 0 (0.0) |
Data are given as number (%). WHO ordinal outcomes scale: A1, died; A2, intubated, survived; A3, hospitalized on oxygen; A4, hospitalized without oxygen; A5, discharged. BMI, body mass index; MGH, Massachusetts General Hospital.